159 related articles for article (PubMed ID: 22319069)
41. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
Zhao L; Zhu W; Zhang X; He D; Guo C
BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
[TBL] [Abstract][Full Text] [Related]
42. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study).
Sheiban I; Sillano D; Biondi-Zoccai G; Chieffo A; Colombo A; Vecchio S; Margheri M; Gunn JP; Raina T; Liistro F; Bolognese L; Lee MS; Tobis J; Moretti C
J Am Coll Cardiol; 2009 Sep; 54(13):1131-6. PubMed ID: 19761932
[TBL] [Abstract][Full Text] [Related]
43. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era.
Lee MS; Pessegueiro A; Zimmer R; Jurewitz D; Tobis J
J Invasive Cardiol; 2008 Aug; 20(8):401-3. PubMed ID: 18688064
[TBL] [Abstract][Full Text] [Related]
44. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
45. Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation.
Kukreja N; Onuma Y; Garcia-Garcia H; Daemen J; van Domburg R; Serruys PW
Circ Cardiovasc Interv; 2008 Oct; 1(2):103-10. PubMed ID: 20031664
[TBL] [Abstract][Full Text] [Related]
46. Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes.
Umeda H; Kawai T; Misumida N; Ota T; Hayashi K; Iwase M; Izawa H; Sugino S; Shimizu T; Takeichi Y; Ishiki R; Inagaki H; Ozaki Y; Murohara T
Circ Cardiovasc Interv; 2011 Aug; 4(4):349-54. PubMed ID: 21813403
[TBL] [Abstract][Full Text] [Related]
47. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
48. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
Abbott JD; Voss MR; Nakamura M; Cohen HA; Selzer F; Kip KE; Vlachos HA; Wilensky RL; Williams DO
J Am Coll Cardiol; 2007 Nov; 50(21):2029-36. PubMed ID: 18021868
[TBL] [Abstract][Full Text] [Related]
49. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
[TBL] [Abstract][Full Text] [Related]
50. Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure.
Negi SI; Torguson R; Gai J; Kiramijyan S; Koifman E; Chan R; Randolph P; Pichard A; Satler LF; Waksman R
JACC Cardiovasc Interv; 2016 Jun; 9(12):1259-1265. PubMed ID: 27339842
[TBL] [Abstract][Full Text] [Related]
51. Safety and efficacy of drug-eluting balloons in the treatment of drug-eluting in-stent restenosis: experience of a tertiary care hospital.
Dhakam S; Jafferani A; Ahmed H; Rahman N; Gowani A
J Invasive Cardiol; 2012 Jul; 24(7):335-8. PubMed ID: 22781472
[TBL] [Abstract][Full Text] [Related]
52. Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease.
Lee JY; Park DW; Kim YH; Yun SC; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
J Am Coll Cardiol; 2011 Mar; 57(12):1349-58. PubMed ID: 21414531
[TBL] [Abstract][Full Text] [Related]
53. Management of drug-eluting stent restenosis.
Ishikawa K; Aoyama Y; Hirayama H
J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
[TBL] [Abstract][Full Text] [Related]
54. Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions.
Kubo S; Kadota K; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tada T; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
EuroIntervention; 2013 Nov; 9(7):788-96. PubMed ID: 24280155
[TBL] [Abstract][Full Text] [Related]
55. Treatment for in-stent restenosis requiring rotational atherectomy.
Hachinohe D; Kashima Y; Hirata K; Kanno D; Kobayashi K; Kaneko U; Sugie T; Tadano Y; Watanabe T; Shitan H; Haraguchi T; Enomoto M; Sato K; Fujita T
J Interv Cardiol; 2018 Dec; 31(6):747-754. PubMed ID: 30175429
[TBL] [Abstract][Full Text] [Related]
56. Late catch-up phenomenon associated with stent fracture after sirolimus-eluting stent implantation: incidence and outcome.
Serikawa T; Kawasaki T; Koga H; Orita Y; Ikeda S; Goto Y; Shintani Y; Kajiwara M; Tanaka H; Fukuyama T; Koga N
J Interv Cardiol; 2011 Apr; 24(2):165-71. PubMed ID: 21198850
[TBL] [Abstract][Full Text] [Related]
57. Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis.
Yang YX; Liu Y; Li CP; Lu PJ; Wang J; Gao J
J Interv Cardiol; 2020; 2020():8179849. PubMed ID: 32684867
[TBL] [Abstract][Full Text] [Related]
58. Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?
Harada Y; Schneider S; Colleran R; Rai H; Bohner J; Kuna C; Kufner S; Giacoppo D; Schüpke S; Joner M; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA
Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):225-231. PubMed ID: 30878234
[TBL] [Abstract][Full Text] [Related]
59. Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis.
Mangione FM; Jatene T; Badr Eslam R; Bergmark BA; Gallagher JR; Shah PB; Mauri L; Leopold JA; Sobieszczyk PS; Faxon DP; Croce KJ; Bhatt DL; Devlin PM
Am J Cardiol; 2017 Aug; 120(3):369-373. PubMed ID: 28583681
[TBL] [Abstract][Full Text] [Related]
60. Drug-eluting stents may not reduce target lesion revascularization in cardiac allograft vasculopathy.
Park KE; Huo T; Muller KE; Aranda JM; Hill JA; Anderson RD
J Interv Cardiol; 2014 Feb; 27(1):80-5. PubMed ID: 24383617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
